Highnoon Laboratories Ltd
Hamza Bilal is the Head of Risk and Advisory at Highnoon. With experience in internal audit advisory and risk management at Highnoon, shared services at CCL Pharmaceuticals, and finance at Rafhan Maize Products, Hamza has a background in auditing and financial reporting. Hamza is a CA and ACCA qualified professional who believes in driving continuous improvement and system utilization.
This person is not in the org chart
This person is not in any teams
Highnoon Laboratories Ltd
Highnoon Laboratories Limited is a Pakistan-based pharmaceutical company. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products. The Company offers products for various therapeutic areas, such as alimentary tract and metabolism, cardiovascular and respiratory products. The Company's product brands for alimentary tract and metabolism include Tres Orix Forte, Ulsanic, Skilax and Tagipmet. The Company's cardiovascular portfolio includes Misar brand, which is an angiotensin receptor blocker (ARB) used in the management of hypertension. Its products include AIRTAL (Aceclofenac), which has non-steroidal, anti-inflammatory and analgesic properties; ARIA (ketotifen), a non-bronchodilator antiasthamatic drug; ARTECXCIN, which acts as a blood schizotocide, and artrodar (diacerein), used for the treatment of inflammation and rheumatism. Its other products include Asthavent, AXESOME, Bezisox and Betatec.